BamSEC and AlphaSense Join Forces
Learn More

King Pharmaceuticals Inc

Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from 8-K 92 pages Agreement and Plan of Merger Dated as of October 11, 2010 Among Pfizer Inc. King Pharmaceuticals, Inc. and Parker Tennessee Corp
12/34/56
EX-2.1
from 8-K 90 pages Agreement and Plan of Merger Dated as of November 23, 2008, Among King Pharmaceuticals, Inc., Albert Acquisition Corp. and Alpharma Inc
12/34/56
EX-2.1
from 8-K 77 pages Agreement
12/34/56
EX-2.1
from 8-K 12 pages Amendment Number 2 to Purchase Agreement
12/34/56
EX-2.2
from 8-K 3 pages December 29, 2006 Brian A. Markinson President and Chief Executive Officer King Pharmaceuticals, Inc. 501 Fifth Street Bristol, Tennessee 37620 via E-Mail and U.S. Email Re: Loan Agreement Dated as October 12, 2006 Dear Brian
12/34/56
EX-2.1
from 8-K 5 pages Amendment Number 1 to Purchase Agreement, Contract Sales Force Agreement and Confidentiality Agreement
12/34/56
EX-2.1
from 8-K 70 pages Purchase Agreement Between Ligand Pharmaceuticals Incorporated and King Pharmaceuticals, Inc. and King Pharmaceuticals Research and Development, Inc. Dated as of September 6, 2006
12/34/56
EX-2
from SC 13D/A ~10 pages Ex-2 Termination Agreement
12/34/56
EX-2.1
from 8-K >50 pages Ex-2.1 Amended & Restated Asset Purch. Agreement
12/34/56
EX-2.2
from 8-K/A ~50 pages Asset Purchase Agreement
12/34/56
EX-2.1
from 8-K/A ~50 pages Asset Purchase Agreement
12/34/56
EX-2
from SC 13G 1 page Identification & Classificatin of Subsidiary
12/34/56
EX-2
from SC 13D ~20 pages Note Purchase Agreement
12/34/56
EX-2
from SC 13D 1 page Joing Filing Agreement
12/34/56
EX-2.1
from 8-K ~20 pages General Products Agreement
12/34/56